BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 23, 2011
View Archived Issues
Intranasal PH-94B spray reduces anxiety in women with social anxiety disorder
Read More
GI-4000 is immunogenic in phase IIa consolidation therapy trial in stage I-III NSCLC
Read More
Promising preclinical data reported on new HIV vaccine based on lumpy skin disease virus
Read More
Amgen designs novel beta-secretase 1 inhibitors for cognition disorders
Read More
Bayer Schering Pharma presents new cancer diagnostic imaging agents
Read More
New melanocortin MC1 receptor agonists synthesized
Read More
Neuralstem cleared to dose final cohort in ongoing phase Ia NSI-189 trial
Read More
Threshold Pharmaceuticals completes enrollment in phase II TH-302 pancreatic cancer trial
Read More
Cel-Sci's anticancer drug Multikine lowers cholesterol in phase II trials
Read More
GC-33 is safe in hepatocellular carcinoma in first-in-human study
Read More
TriMix-DC vaccine is safe and immunogenic in phase I trial in pretreated melanoma
Read More
Algeta receives grant to develop novel tumor-targeted thorium conjugates
Read More
MicroRNA-155 may be a marker of metabolic syndrome
Read More
New antibacterial FabI inhibitors synthesized by FAB Pharma
Read More
Yissum Research Development patents new cannabinoid CB2 receptor ligands
Read More
Seaside Therapeutics begins phase IIb STX-209 trial in autism spectrum disorders
Read More
Luminex to acquire EraGen Biosciences
Read More
Merck KGaA discontinues approval process for cladribine tablets in MS
Read More
Abbott and Biotest enter agreement to develop and commercialize BT-06 for autoimmune diseases
Read More
FDA approves CorMedix's SPA for phase III CRMD-001 trial
Read More
Achillion begins dosing in second segment of phase IIa ACH-1625 trial in chronic hepatitis C
Read More
Infinity Pharmaceuticals expands development program for anticancer agent IPI-926
Read More
Ligand Pharmaceuticals to advance Captisol-enabled melphalan program
Read More
NanoBio starts phase Ib trial of intranasal influenza vaccine
Read More
FDA approves personalized cell therapy laViv to improve appearance of smile lines
Read More
Enrollment begins in phase II RP-G28 trial in patients with lactose intolerance
Read More
